speb/financial-data huggingface dataset:
BCTXZ cash_flow (quarterly, 2025-01-31) — Purchase Of Business: -75000.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Receivables: 2148919.00
BCTXZ income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 26657.00
BCTXZ income_statement (quarterly, 2025-01-31) — Research And Development: 5684777.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Retained Earnings: -97537292.00
BCTXZ income_statement (quarterly, 2025-01-31) — Selling General And Administration: 1484666.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Share Issued: 294694.00
BCTXZ cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 285093.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 3602922.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 3410762.00
BCTXZ income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
BCTXZ income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Total Assets: 9363567.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 3602922.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 3226891.00
BCTXZ income_statement (quarterly, 2025-01-31) — Total Expenses: 7169443.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 6136676.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 2200994.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 905838.00
BCTXZ income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: -7169443.00
BCTXZ income_statement (quarterly, 2025-01-31) — Total Unusual Items: 827367.00
BCTXZ income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: 827367.00
BCTXZ balance_sheet (quarterly, 2025-01-31) — Working Capital: 1931735.00
BCTXZ income_statement (quarterly, 2025-04-30) — +Operating Expense: 6328255.00
BCTXZ income_statement (quarterly, 2025-04-30) — +Total Revenue: 0.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 3279204.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 2324945.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Amortization Cash Flow: 3817.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Amortization Of Intangibles: 3817.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 5013654.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Capital Stock: 94022525.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 12460253.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 12460253.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: 14714376.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -105000.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: -7162777.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Change In Account Payable: -1724035.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Change In Accrued Expense: 823830.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Change In Payable: -1724035.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: -900205.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: -185969.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Change In Receivables: -176026.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Change In Working Capital: -1076231.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Changes In Cash: 7446599.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Common Stock: 94022525.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 12415211.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Common Stock Issuance: 14714376.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 1051429.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Current Assets: 14785198.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 4330633.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Depreciation: 22839.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 26656.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 26656.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Derivative Product Liabilities: 730012.00
BCTXZ income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -6126902.00
BCTXZ income_statement (quarterly, 2025-04-30) — EBIT: -6187950.00
BCTXZ income_statement (quarterly, 2025-04-30) — EBITDA: -6161294.00
BCTXZ income_statement (quarterly, 2025-04-30) — Earnings From Equity Interest: -62738.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Earnings Losses From Equity Investments: 62738.00
BCTXZ cash_flow (quarterly, 2025-04-30) — End Cash Position: 12460253.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: 14714376.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Free Cash Flow: -7162777.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Gain Loss On Investment Securities: -175826.00
BCTXZ income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: 176411.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTXZ income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 1518059.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 188343.00
BCTXZ income_statement (quarterly, 2025-04-30) — Interest Expense: 36979.00
BCTXZ income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 36979.00
BCTXZ income_statement (quarterly, 2025-04-30) — Interest Income: 26632.00
BCTXZ income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 26632.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Invested Capital: 12415211.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -105000.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Investments And Advances: 496653.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Investmentsin Subsidiariesat Cost: 496653.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Issuance Of Capital Stock: 14714376.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Long Term Equity Investment: 496653.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Minority Interest: -474058.00
BCTXZ income_statement (quarterly, 2025-04-30) — Minority Interests: 98027.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Net Business Purchase And Sale: -105000.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: 14714376.00
BCTXZ income_statement (quarterly, 2025-04-30) — Net Income: -6126902.00
BCTXZ income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -6126902.00
BCTXZ income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: -6224929.00
BCTXZ income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -6126902.00
BCTXZ income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -6126902.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: -6224929.00
BCTXZ income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: -6224929.00
BCTXZ income_statement (quarterly, 2025-04-30) — Net Interest Income: -10347.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: 0.00
BCTXZ income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -10347.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Net PPE: 319658.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 12226868.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Non Current Prepaid Assets: 1211946.00
BCTXZ income_statement (quarterly, 2025-04-30) — Normalized EBITDA: -6337705.00
BCTXZ income_statement (quarterly, 2025-04-30) — Normalized Income: -6303313.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: -7162777.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: -113088.00
BCTXZ income_statement (quarterly, 2025-04-30) — Operating Income: -6328255.00
BCTXZ income_statement (quarterly, 2025-04-30) — Operating Revenue: 0.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 655809.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: -138684.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Other Equity Interest: 22195564.00
BCTXZ income_statement (quarterly, 2025-04-30) — Other Gand A: 1518059.00
BCTXZ income_statement (quarterly, 2025-04-30) — Other Income Expense: 113673.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Payables: 3279204.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 4330633.00
BCTXZ income_statement (quarterly, 2025-04-30) — Pretax Income: -6224929.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: 0.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Purchase Of Business: -105000.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Receivables: 2324945.00
BCTXZ income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 26656.00
BCTXZ income_statement (quarterly, 2025-04-30) — Research And Development: 4810196.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Retained Earnings: -103664194.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 0.00
BCTXZ income_statement (quarterly, 2025-04-30) — Selling General And Administration: 1518059.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Share Issued: 655809.00
BCTXZ cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 224815.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 12415211.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 12226868.00
BCTXZ income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 0.00
BCTXZ income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Total Assets: 17001798.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 12415211.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 11941153.00
BCTXZ income_statement (quarterly, 2025-04-30) — Total Expenses: 6328255.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 5060645.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 2216600.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 730012.00
BCTXZ income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: -6328255.00
BCTXZ income_statement (quarterly, 2025-04-30) — Total Unusual Items: 176411.00
BCTXZ income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: 176411.00
BCTXZ balance_sheet (quarterly, 2025-04-30) — Working Capital: 10454565.00
BCTXZ income_statement (quarterly, 2025-10-31) — +Operating Expense: 8322943.00
BCTXZ income_statement (quarterly, 2025-10-31) — +Total Revenue: 0.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 2128915.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 1172435.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Amortization Cash Flow: 3818.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Amortization Of Intangibles: 3818.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 10493808.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Capital Stock: 101739923.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 2714012.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 10175972.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: 0.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -75000.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: -7704796.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Change In Account Payable: -1154788.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Change In Accrued Expense: 494573.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Change In Payable: -1154788.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: -660215.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Change In Receivables: 887860.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Change In Working Capital: 227645.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Changes In Cash: -7779796.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Common Stock: 101739923.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 9977962.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Common Stock Issuance: 0.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 1188858.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Current Assets: 11348407.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 3317773.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Depreciation: 22839.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 26657.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 26657.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Derivative Product Liabilities: 406873.00
BCTXZ income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: -8197565.00
BCTXZ income_statement (quarterly, 2025-10-31) — EBIT: -8322943.00
BCTXZ income_statement (quarterly, 2025-10-31) — EBITDA: -8296286.00
BCTXZ income_statement (quarterly, 2025-10-31) — Earnings From Equity Interest: -44830.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Earnings Losses From Equity Investments: 44830.00
BCTXZ cash_flow (quarterly, 2025-10-31) — End Cash Position: 2714012.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: 0.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Free Cash Flow: -7704796.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Gain Loss On Investment Securities: 69201.00
BCTXZ income_statement (quarterly, 2025-10-31) — Gain On Sale Of Security: 40963.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTXZ income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 1639300.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 180707.00
BCTXZ income_statement (quarterly, 2025-10-31) — Interest Income: 48482.00
BCTXZ income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 48482.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Invested Capital: 9977962.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -75000.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Investments And Advances: 554448.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Investmentsin Subsidiariesat Cost: 554448.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Issuance Of Capital Stock: 0.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Long Term Equity Investment: 554448.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Minority Interest: -627558.00
BCTXZ income_statement (quarterly, 2025-10-31) — Minority Interests: 80763.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Net Business Purchase And Sale: -75000.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: 0.00
BCTXZ income_statement (quarterly, 2025-10-31) — Net Income: -8197565.00
BCTXZ income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: -8197565.00
BCTXZ income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: -8278328.00
BCTXZ income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: -8197565.00
BCTXZ income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: -8197565.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: -8278328.00
BCTXZ income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: -8278328.00
BCTXZ income_statement (quarterly, 2025-10-31) — Net Interest Income: 48482.00
BCTXZ income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: 48482.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Net PPE: 273980.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 9797255.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Non Current Prepaid Assets: 717508.00
BCTXZ income_statement (quarterly, 2025-10-31) — Normalized EBITDA: -8337249.00
BCTXZ income_statement (quarterly, 2025-10-31) — Normalized Income: -8238528.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: -7704796.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: 114031.00
BCTXZ income_statement (quarterly, 2025-10-31) — Operating Income: -8322943.00
BCTXZ income_statement (quarterly, 2025-10-31) — Operating Revenue: 0.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 1883906.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: -138684.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Other Equity Interest: 28329852.00
BCTXZ income_statement (quarterly, 2025-10-31) — Other Gand A: 1639300.00
BCTXZ income_statement (quarterly, 2025-10-31) — Other Income Expense: -3867.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: -89487.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 7461960.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Payables: 2128915.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 3317773.00
BCTXZ income_statement (quarterly, 2025-10-31) — Pretax Income: -8278328.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Proceeds From Stock Option Exercised: 0.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Purchase Of Business: -75000.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Receivables: 1172435.00
BCTXZ income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 26657.00
BCTXZ income_statement (quarterly, 2025-10-31) — Research And Development: 6683643.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Retained Earnings: -119953129.00
BCTXZ income_statement (quarterly, 2025-10-31) — Selling General And Administration: 1639300.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Share Issued: 1883906.00
BCTXZ cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 294686.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 9977962.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 9797255.00
BCTXZ income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
BCTXZ income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Total Assets: 13075050.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 9977962.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 9350404.00
BCTXZ income_statement (quarterly, 2025-10-31) — Total Expenses: 8322943.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 3724646.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 1726643.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 406873.00
BCTXZ income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: -8322943.00
BCTXZ income_statement (quarterly, 2025-10-31) — Total Unusual Items: 40963.00
BCTXZ income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: 40963.00
BCTXZ balance_sheet (quarterly, 2025-10-31) — Working Capital: 8030634.00
BCTXZ income_statement (quarterly, 2026-01-31) — +Operating Expense: 7531266.00
BCTXZ income_statement (quarterly, 2026-01-31) — +Total Revenue: 0.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 1879647.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 2275256.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Amortization Cash Flow: 3818.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Amortization Of Intangibles: 3818.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 2714012.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Capital Stock: 117117225.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 29903628.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 29903628.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: 27874441.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: 7282473.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: -7967298.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Change In Account Payable: -249268.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Change In Accrued Expense: 117045.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Change In Payable: -249268.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: -132223.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Change In Receivables: -790398.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -922621.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Changes In Cash: 27189616.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Common Stock: 117117225.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 30916439.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Common Stock Issuance: 27874441.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 1305903.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Current Assets: 32178884.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 3185550.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Depreciation: 22839.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 26657.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 26657.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Derivative Product Liabilities: 195096.00
BCTXZ income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: -7221820.00
BCTXZ income_statement (quarterly, 2026-01-31) — EBIT: -7531266.00
BCTXZ income_statement (quarterly, 2026-01-31) — EBITDA: -7504609.00
BCTXZ income_statement (quarterly, 2026-01-31) — Earnings From Equity Interest: -61993.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Earnings Losses From Equity Investments: 61993.00
BCTXZ cash_flow (quarterly, 2026-01-31) — End Cash Position: 29903628.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: 27874441.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Free Cash Flow: -7967298.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Gain Loss On Investment Securities: -211777.00
BCTXZ income_statement (quarterly, 2026-01-31) — Gain On Sale Of Security: 190728.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTXZ income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 1477577.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 176889.00
BCTXZ income_statement (quarterly, 2026-01-31) — Interest Income: 105638.00
BCTXZ income_statement (quarterly, 2026-01-31) — Interest Income Non Operating: 105638.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Invested Capital: 30916439.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: 7282473.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Investments And Advances: 582455.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Investmentsin Subsidiariesat Cost: 582455.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Issuance Of Capital Stock: 27874441.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Long Term Equity Investment: 582455.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Minority Interest: -702631.00
BCTXZ income_statement (quarterly, 2026-01-31) — Minority Interests: 75073.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Net Business Purchase And Sale: -90000.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 27874441.00
BCTXZ income_statement (quarterly, 2026-01-31) — Net Income: -7221820.00
BCTXZ income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: -7221820.00
BCTXZ income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: -7296893.00
BCTXZ income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: -7221820.00
BCTXZ income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: -7221820.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: -7296893.00
BCTXZ income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: -7296893.00
BCTXZ income_statement (quarterly, 2026-01-31) — Net Interest Income: 105638.00
BCTXZ income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: 105638.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Net PPE: 251141.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 30739550.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Non Current Prepaid Assets: 405085.00
BCTXZ income_statement (quarterly, 2026-01-31) — Normalized EBITDA: -7695337.00
BCTXZ income_statement (quarterly, 2026-01-31) — Normalized Income: -7412548.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: -7967298.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: -149784.00
BCTXZ income_statement (quarterly, 2026-01-31) — Operating Income: -7531266.00
BCTXZ income_statement (quarterly, 2026-01-31) — Operating Revenue: 0.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 7250487.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: -138684.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Other Equity Interest: 41112847.00
BCTXZ income_statement (quarterly, 2026-01-31) — Other Gand A: 1477577.00
BCTXZ income_statement (quarterly, 2026-01-31) — Other Income Expense: 128735.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Other Short Term Investments: 0.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Payables: 1879647.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 3185550.00
BCTXZ income_statement (quarterly, 2026-01-31) — Pretax Income: -7296893.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Proceeds From Stock Option Exercised: 0.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Purchase Of Business: -90000.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Receivables: 2275256.00
BCTXZ income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 26657.00
BCTXZ income_statement (quarterly, 2026-01-31) — Research And Development: 6053689.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Retained Earnings: -127174949.00
BCTXZ income_statement (quarterly, 2026-01-31) — Selling General And Administration: 1477577.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Share Issued: 7250487.00
BCTXZ cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 285856.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 30916439.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 30739550.00
BCTXZ income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 0.00
BCTXZ income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Total Assets: 33594454.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 30916439.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 30213808.00
BCTXZ income_statement (quarterly, 2026-01-31) — Total Expenses: 7531266.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 3380646.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 1415570.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 195096.00
BCTXZ income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: -7531266.00
BCTXZ income_statement (quarterly, 2026-01-31) — Total Unusual Items: 190728.00
BCTXZ income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: 190728.00
BCTXZ balance_sheet (quarterly, 2026-01-31) — Working Capital: 28993334.00
BCTXZ income_statement (quarterly, 2026-04-30) — +Operating Expense: 7620794.00
BCTXZ income_statement (quarterly, 2026-04-30) — +Total Revenue: 0.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 2174437.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 2588749.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Amortization Cash Flow: 3817.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Amortization Of Intangibles: 3817.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 29903628.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Capital Stock: 117117225.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 6880221.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 22804425.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: 0.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -16003049.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: -7020358.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 294790.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Change In Accrued Expense: 110156.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Change In Payable: 294790.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 404946.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Change In Receivables: -313493.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Change In Working Capital: 91453.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Changes In Cash: -23023407.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Common Stock: 117117225.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 24058059.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Common Stock Issuance: 0.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 1416059.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Current Assets: 25393174.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 3590496.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Depreciation: 29193.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 33010.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 33010.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Derivative Product Liabilities: 71854.00
BCTXZ income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: -7164507.00
BCTXZ income_statement (quarterly, 2026-04-30) — EBIT: -7207424.00
BCTXZ income_statement (quarterly, 2026-04-30) — EBITDA: -7174414.00
BCTXZ income_statement (quarterly, 2026-04-30) — Earnings From Equity Interest: -64303.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Earnings Losses From Equity Investments: 64303.00
BCTXZ cash_flow (quarterly, 2026-04-30) — End Cash Position: 6880221.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: 0.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Free Cash Flow: -7147407.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Gain Loss On Investment Securities: -261072.00
BCTXZ income_statement (quarterly, 2026-04-30) — Gain On Sale Of Security: 258453.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTXZ income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 1654121.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 173072.00
BCTXZ income_statement (quarterly, 2026-04-30) — Interest Expense: 29631.00
BCTXZ income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 29631.00
BCTXZ income_statement (quarterly, 2026-04-30) — Interest Income: 219220.00
BCTXZ income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 219220.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Invested Capital: 24058059.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -16003049.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Investments And Advances: 750982.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Investmentsin Subsidiariesat Cost: 750982.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Issuance Of Capital Stock: 0.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Long Term Equity Investment: 750982.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Minority Interest: -649099.00
BCTXZ income_statement (quarterly, 2026-04-30) — Minority Interests: 72548.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Net Business Purchase And Sale: -95000.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: 0.00
BCTXZ income_statement (quarterly, 2026-04-30) — Net Income: -7164507.00
BCTXZ income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: -7164507.00
BCTXZ income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: -7237055.00
BCTXZ income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: -7164507.00
BCTXZ income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: -7164507.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: -7237055.00
BCTXZ income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: -7237055.00
BCTXZ income_statement (quarterly, 2026-04-30) — Net Interest Income: 189589.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: -15781000.00
BCTXZ income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 189589.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Net PPE: 348997.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 23884987.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Non Current Prepaid Assets: 405085.00
BCTXZ income_statement (quarterly, 2026-04-30) — Normalized EBITDA: -7432867.00
BCTXZ income_statement (quarterly, 2026-04-30) — Normalized Income: -7422960.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: -7020358.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: -196769.00
BCTXZ income_statement (quarterly, 2026-04-30) — Operating Income: -7620794.00
BCTXZ income_statement (quarterly, 2026-04-30) — Operating Revenue: 0.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 7250487.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: -138684.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Other Equity Interest: 41418974.00
BCTXZ income_statement (quarterly, 2026-04-30) — Other Gand A: 1654121.00
BCTXZ income_statement (quarterly, 2026-04-30) — Other Income Expense: 194150.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Other Short Term Investments: 15924204.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Payables: 2174437.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 3590496.00
BCTXZ income_statement (quarterly, 2026-04-30) — Pretax Income: -7237055.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Proceeds From Stock Option Exercised: 0.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Purchase Of Business: -95000.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Receivables: 2588749.00
BCTXZ income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 33010.00
BCTXZ income_statement (quarterly, 2026-04-30) — Research And Development: 5966673.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Retained Earnings: -134339456.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Sale Of Investment: 0.00
BCTXZ income_statement (quarterly, 2026-04-30) — Selling General And Administration: 1654121.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Share Issued: 7250487.00
BCTXZ cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 432207.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 24058059.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 23884987.00
BCTXZ income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
BCTXZ income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Total Assets: 27071310.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 24058059.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 23408960.00
BCTXZ income_statement (quarterly, 2026-04-30) — Total Expenses: 7620794.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 3662350.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 1678136.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 71854.00
BCTXZ income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: -7620794.00
BCTXZ income_statement (quarterly, 2026-04-30) — Total Unusual Items: 258453.00
BCTXZ income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: 258453.00
BCTXZ balance_sheet (quarterly, 2026-04-30) — Working Capital: 21802678.00
BCU.V balance_sheet (annual, 2021-12-31) — Accounts Payable: 893735.00
BCU.V balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -2584.00
BCU.V cash_flow (annual, 2021-12-31) — Asset Impairment Charge: -1845190.00
BCU.V cash_flow (annual, 2021-12-31) — Capital Expenditure: -2619901.00
BCU.V cash_flow (annual, 2021-12-31) — Change In Account Payable: 151594.00
BCU.V cash_flow (annual, 2021-12-31) — Change In Other Working Capital: 99687.00
BCU.V cash_flow (annual, 2021-12-31) — Change In Payable: 151594.00
BCU.V balance_sheet (annual, 2021-12-31) — Gross PPE: 7731185.00
BCU.V cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 0.00
BCU.V cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -2619901.00
BCU.V balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 0.00
BCU.V cash_flow (annual, 2021-12-31) — Other Non Cash Items: -570135.00
BCU.V income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -287841.00
BCU.V balance_sheet (annual, 2021-12-31) — Other Properties: 7731185.00
BCU.V income_statement (annual, 2021-12-31) — Other Special Charges: -2415398.00
BCU.V balance_sheet (annual, 2021-12-31) — Payables: 893735.00
BCU.V cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 342861.00
BCU.V cash_flow (annual, 2021-12-31) — Purchase Of Investment: 0.00
BCU.V cash_flow (annual, 2021-12-31) — Purchase Of PPE: -2619901.00
BCU.V income_statement (annual, 2021-12-31) — Special Income Charges: 2415398.00
BCU.V income_statement (annual, 2021-12-31) — Write Off: -2133104.00
BCU.V income_statement (annual, 2022-12-31) — +Operating Expense: 2332962.00
BCU.V income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
BCU.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 382348.00
BCU.V balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -6560.00
BCU.V balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3860039.00
BCU.V cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
BCU.V income_statement (annual, 2022-12-31) — Basic Average Shares: 119774855.00
BCU.V income_statement (annual, 2022-12-31) — Basic EPS: -0.02
BCU.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 191062.00
BCU.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -1440247.00
BCU.V balance_sheet (annual, 2022-12-31) — Capital Stock: 72770087.00
BCU.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 57364.00
BCU.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 57364.00
BCU.V balance_sheet (annual, 2022-12-31) — Cash Financial: 57364.00
BCU.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 2637381.00
BCU.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1495572.00
BCU.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -1276739.00
BCU.V cash_flow (annual, 2022-12-31) — Change In Account Payable: -511387.00
BCU.V cash_flow (annual, 2022-12-31) — Change In Payable: -511387.00
BCU.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -511387.00
BCU.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -135440.00
BCU.V cash_flow (annual, 2022-12-31) — Change In Receivables: 12246.00
BCU.V cash_flow (annual, 2022-12-31) — Change In Working Capital: -634581.00
BCU.V cash_flow (annual, 2022-12-31) — Changes In Cash: -134930.00
BCU.V balance_sheet (annual, 2022-12-31) — Common Stock: 72770087.00
BCU.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 9372012.00
BCU.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 172880.00
BCU.V income_statement (annual, 2022-12-31) — Cost Of Revenue: 5364.00
BCU.V balance_sheet (annual, 2022-12-31) — Current Assets: 196021.00
BCU.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 382348.00
BCU.V cash_flow (annual, 2022-12-31) — Depreciation: 5364.00
BCU.V cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 5364.00
BCU.V cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 5364.00
BCU.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 119774855.00
BCU.V income_statement (annual, 2022-12-31) — Diluted EPS: -0.02
BCU.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -2337617.00
BCU.V income_statement (annual, 2022-12-31) — EBIT: -2338326.00
BCU.V income_statement (annual, 2022-12-31) — EBITDA: -2332962.00
BCU.V cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 1232.00
BCU.V cash_flow (annual, 2022-12-31) — End Cash Position: 57364.00
BCU.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: 2637381.00
BCU.V cash_flow (annual, 2022-12-31) — Free Cash Flow: -2716986.00
BCU.V income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 709.00
BCU.V balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 406469.00
BCU.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 2100267.00
BCU.V balance_sheet (annual, 2022-12-31) — Gross PPE: 9558339.00
BCU.V income_statement (annual, 2022-12-31) — Gross Profit: -5364.00
BCU.V income_statement (annual, 2022-12-31) — Insurance And Claims: 26507.00
BCU.V balance_sheet (annual, 2022-12-31) — Invested Capital: 9372012.00
BCU.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1495572.00
BCU.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 172880.00
BCU.V balance_sheet (annual, 2022-12-31) — Long Term Provisions: 173966.00
BCU.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 172880.00
BCU.V cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -879.00
BCU.V income_statement (annual, 2022-12-31) — Net Income: -2337617.00
BCU.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -2337617.00
BCU.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -2337617.00
BCU.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -2337617.00
BCU.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -2337617.00
BCU.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -2337617.00
BCU.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -2337617.00
BCU.V cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -135440.00
BCU.V cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -55325.00
BCU.V balance_sheet (annual, 2022-12-31) — Net PPE: 9558339.00
BCU.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1440247.00
BCU.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 9372012.00
BCU.V balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 135440.00
BCU.V income_statement (annual, 2022-12-31) — Normalized EBITDA: -2333671.00
BCU.V income_statement (annual, 2022-12-31) — Normalized Income: -2338326.00
BCU.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1276739.00
BCU.V cash_flow (annual, 2022-12-31) — Operating Gains Losses: -879.00
BCU.V income_statement (annual, 2022-12-31) — Operating Income: -2338326.00
BCU.V income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
BCU.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 123501811.00
BCU.V balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 406469.00
BCU.V balance_sheet (annual, 2022-12-31) — Other Equity Interest: 5000.00
BCU.V income_statement (annual, 2022-12-31) — Other Gand A: 382786.00
BCU.V income_statement (annual, 2022-12-31) — Other Income Expense: 709.00
BCU.V balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 173966.00
BCU.V income_statement (annual, 2022-12-31) — Other Operating Expenses: 232695.00
BCU.V balance_sheet (annual, 2022-12-31) — Other Properties: 9558339.00
BCU.V balance_sheet (annual, 2022-12-31) — Payables: 382348.00
BCU.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 382348.00
BCU.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 135440.00
BCU.V income_statement (annual, 2022-12-31) — Pretax Income: -2337617.00
BCU.V cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 2464501.00
BCU.V cash_flow (annual, 2022-12-31) — Purchase Of Investment: -135440.00
BCU.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1440247.00
BCU.V balance_sheet (annual, 2022-12-31) — Receivables: 3217.00
BCU.V income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 5364.00
BCU.V income_statement (annual, 2022-12-31) — Reconciled Depreciation: 5364.00
BCU.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -67669583.00
BCU.V income_statement (annual, 2022-12-31) — Salaries And Wages: 1690974.00
BCU.V income_statement (annual, 2022-12-31) — Selling General And Administration: 2100267.00
BCU.V balance_sheet (annual, 2022-12-31) — Share Issued: 123501811.00
BCU.V income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
BCU.V cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1690974.00
BCU.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: 9372012.00
BCU.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: 9372012.00
BCU.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BCU.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
BCU.V balance_sheet (annual, 2022-12-31) — Taxes Receivable: 3217.00
BCU.V balance_sheet (annual, 2022-12-31) — Total Assets: 9928326.00
BCU.V balance_sheet (annual, 2022-12-31) — Total Capitalization: 9372012.00
BCU.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 9372012.00
BCU.V income_statement (annual, 2022-12-31) — Total Expenses: 2338326.00
BCU.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 556314.00
BCU.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 9732305.00
BCU.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 173966.00
BCU.V income_statement (annual, 2022-12-31) — Total Unusual Items: 709.00
BCU.V income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 709.00
BCU.V balance_sheet (annual, 2022-12-31) — Working Capital: -186327.00
BCU.V income_statement (annual, 2023-12-31) — +Operating Expense: 1209220.00
BCU.V income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
BCU.V balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 4473857.00
BCU.V income_statement (annual, 2023-12-31) — Basic Average Shares: 127213984.00
BCU.V income_statement (annual, 2023-12-31) — Basic EPS: -0.01
BCU.V cash_flow (annual, 2023-12-31) — Beginning Cash Position: 57364.00
BCU.V cash_flow (annual, 2023-12-31) — Capital Expenditure: -564576.00
BCU.V balance_sheet (annual, 2023-12-31) — Capital Stock: 73594197.00
BCU.V balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 11678.00
BCU.V balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 11678.00
BCU.V balance_sheet (annual, 2023-12-31) — Cash Financial: 11678.00
BCU.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 819110.00